Insys to Pay $225 Million to Settle U.S. Opioid-Sales Probes - Bloom...

06/05/19

Insys to Pay $225 Million to Settle U.S. Opioid-Sales Probes  Bloomberg

Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle ...

[more]